Friday Mar 29, 2024
Friday Mar 29, 2024

EU agency: No restrictions on AstraZeneca shot


Nepalnews
2021 Apr 07, 20:24, LONDON
FILE - A pharmacist prepares a syringe from a vial of the AstraZeneca coronavirus vaccine during preparations at the Vaccine Village in Antwerp, Belgium, on Friday, February 19, 2021. Photo: AP via RSS

The European Union’s drug regulator says it has found a “possible link” between the AstraZeneca coronavirus vaccine and a rare clotting disorder but says the benefits of the shot still outweigh risks.

In a statement released Wednesday, the European Medicines Agency placed no new restrictions on using the vaccine in people 18 and over.

The EMA says most of the cases reported have occurred in women under 60 within two weeks of vaccination. The agency says based on the currently available evidence, it was not able to identify specific risk factors.

Experts reviewed several dozen cases that came mainly from Europe and the United Kingdom, where around 25 million people have received the AstraZeneca vaccine.

The EMA, the World Health Organization and numerous other health authorities have repeatedly stated the AstraZeneca vaccine is safe and effective and the protection it offers against COVID-19 outweighs the small risks of rare blood clots.

READ ALSO:

European Union drug regulator AstraZeneca coronavirus vaccine rare clotting disorder European Medicines Agency
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

KMC-02, UttarDhoka,
Lazimpat, Nepal

Newsroom
+977–01–4445751 / 4445754

E-mail
[email protected] [email protected]

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal